FIELD: medicine.
SUBSTANCE: while diagnosing cholecystitis and cholelithiasis due to ultrasound testing one should additionally study blood plasma and bile to detect there the content of prostaglandins PGE2 and PGF2α. At PGE2/PGF2α ratio in blood plasma being equal to 6 and more, and, also, at decreased level of biliary cholecystokinin-pancreosimin by 38% and more, biliary PGE2 by 59% and more and increased level of biliary prostaglandin PGF2α by 5.9 times and more against the norm one should diagnose chlecystitis and cholelithiasis. The innovation enables to detect the above-mentioned diseases at earlier stage.
EFFECT: higher accuracy of diagnostics.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EARLY DIAGNOSTICS OF CHOLELITHIASIS | 2004 |
|
RU2254809C1 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR CHOLELITHIASIS, CHOLESTEROSIS AND GALL BLADDER POLYPS | 2008 |
|
RU2367353C1 |
METHOD OF PREDICTION OF POSTCHOLECYSTECTOMY SYNDROME DEVELOPMENT | 2007 |
|
RU2337617C1 |
METHOD FOR DIAGNOSING GALLBLADDER CHOLESTEROSIS | 2004 |
|
RU2276967C2 |
METHOD OF PREDICTION OF CHOLELITHIASIS | 2006 |
|
RU2324944C1 |
METHOD FOR EARLY PREDICTING CHOLELITHIASIS | 2003 |
|
RU2250466C1 |
METHOD OF EARLY RECOGNITION OF CHOLEDOCHOLITHIASIS | 2004 |
|
RU2256922C1 |
DRUG FOR TREATING PATIENTS SUFFERING FROM CHRONIC CHOLECYSTITIS | 2003 |
|
RU2257905C2 |
DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR HEPATIC STEATOSIS AND STEATOHEPATITIS | 2013 |
|
RU2545990C2 |
METHOD FOR DIAGNOSING THE CASES OF CHRONIC HEPATITIS | 2003 |
|
RU2255659C1 |
Authors
Dates
2005-11-10—Published
2004-03-11—Filed